The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

This educational hub has been supported by Boehringer Ingelheim. Boehringer Ingelheim has had no influence over the content. This educational hub is not intended for UK or IRELAND based physicians.

Close X
Other videos you might like

Recent Videos


ECO 23: Impact of Obesity on Heart Failure Outcomes

Laura Meems,

Watch time: 7m 7s

Video Series

What Matters to Patients: Metabolic Health Beyond Weight Loss

Filip Knop, Jason Halford, Fatima Cody Stanford, et al

Watch time: 1m 40s (5 videos)

Video Series

e-SPACE Cardio-Renal-Metabolic 2023

Fausto J Pinto, Kerri L Cavanaugh, John Spertus, et al

Watch time: 16h 19m 46s (19 videos)


Obesity Management Strategies in 2023

Harold Bays,

Watch time: 17m 7s
Impact of BMI and Type of Ablation Procedure on Atrial Fibrillation Recurrence in Japanese Patients

Journal of Asian Pacific Society of Cardiology 2022;1:e15.

Bariatric Surgery Supported With Transvalvular Pumps: New Strategy for Morbidly Obese Patients to Get to Heart Transplantation

Interventional Cardiology Review 2022;17(Suppl 1):25.

Obesity and Atrial Fibrillation: Epidemiology, Pathogenesis and Effect of Weight Loss

Arrhythmia & Electrophysiology Review 2021;10(3):159–64.

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease

European Cardiology Review 2020;15:e04.

Evaluation of the Effect of Heart Failure Reversal Therapy on Anthropometric Obesity Parameters in Patients with Chronic Heart Failure: A Retrospective Analysis

European Cardiology Review 2020;15:e37.

Impacts of Adipocytokines and Obesity-associated Inflammatory Markers on Apolipoprotein A-1 and B in Patients on Statin Therapy

European Cardiology Review 2020;15:e45.

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence

European Cardiology Review 2019;14(1):60–1

Relationship Between Obstructive Sleep Apnoea and AF

Arrhythmia & Electrophysiology Review 2019;8(3):180–3.

Obesity and Weight Loss

European Cardiology Review 2018;13(2):93–4.

Obesity and Atrial Fibrillation: Epidemiology, Pathophysiology and Novel Therapeutic Opportunities

Arrhythmia & Electrophysiology Review 2019;8(1):28–36.

Left Ventricular Remodelling: A Problem in Search of Solutions

European Cardiology Review 2016;11(1):29–35

What is Takotsubo (Stress) Cardiomyopathy?

European Cardiology Review 2015;10(1):6–8


US Cardiology, 2006;3(1):11

How Do We Approach Low High-density Lipoprotein Cholesterol in 2011?

European Cardiology 2011;7(4):257–63

American Heart Association's Shared Focus is Critical to Achieving its Goals Faster

US Cardiology 2005;2(1):18–9

Excess Body Weight and Coronary Artery Disease - Associated Risks, the Obesity Paradox, and Implications for Cardiac Rehabilitation

US Cardiology 2011;8(2):88–93

The Million Hearts Initiative - Targeting Key Drivers of Cardiovascular Mortality from a Medical Specialty Society Perspective

US Cardiology 2012;9(1):66-70

Biomarkers Associated with Cardiometabolic Risk in Obesity

American Heart Hospital Journal 2011;9(1):28-32

High Prevalence of Obesity in Young Patients with ST Elevation Myocardial Infarction

American Heart Hospital Journal 2011;9(1):37-40

Tackling Childhood Obesity as a Strategy in Cardiovascular Risk Reduction

European Cardiology 2011;7(3):160–3